We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-5.64%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$741B
AUM Growth
-$68.4B
Cap. Flow
-$3.25B
Cap. Flow %
-0.44%
Top 10 Hldgs %
15.48%
Holding
8,434
New
238
Increased
3,520
Reduced
3,560
Closed
255

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$2.61B
2
EPAM icon
EPAM Systems
EPAM
+$1.48B
3
TWLO icon
Twilio
TWLO
+$1.35B
4
AAPL icon
Apple
AAPL
+$1.24B
5
TWTR
Twitter, Inc.
TWTR
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 18.54%
2 Healthcare 9.8%
3 Financials 9.16%
4 Consumer Discretionary 8.42%
5 Communication Services 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRDN icon
5076
Viridian Therapeutics
VRDN
$2.5B
$646K ﹤0.01%
34,929
+21,234
+155% +$408K
CXH
5077
DELISTED
MFS Investment Grade Municipal Trust
CXH
$645K ﹤0.01%
75,533
+3,332
+5% +$30.4K
INDI icon
5078
indie Semiconductor
INDI
$934M
$645K ﹤0.01%
82,690
-80,197
-49% -$658K
NMI icon
5079
Nuveen Municipal Income
NMI
$127M
$645K ﹤0.01%
64,430
-6,107
-9% -$64.7K
SCWX
5080
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$645K ﹤0.01%
48,691
+27,681
+132% +$395K
CCB icon
5081
Coastal Financial
CCB
$792M
$644K ﹤0.01%
14,066
+9,013
+178% +$438K
ICCC icon
5082
ImmuCell
ICCC
$91.6M
$644K ﹤0.01%
66,774
+10,300
+18% +$88.9K
FBCG
5083
Fidelity Blue Chip Growth ETF
FBCG
$7.3B
$642K ﹤0.01%
21,237
SIGA icon
5084
SIGA Technologies
SIGA
$214M
$642K ﹤0.01%
90,619
-19,695
-18% -$132K
BNO icon
5085
United States Brent Oil Fund
BNO
$786M
$638K ﹤0.01%
21,307
+2,295
+12% +$61.3K
ACNB icon
5086
ACNB Corp
ACNB
$656M
$637K ﹤0.01%
18,239
+2,018
+12% +$66.8K
ATLC icon
5087
Atlanticus Holdings
ATLC
$1.53B
$637K ﹤0.01%
12,285
+3,617
+42% +$217K
FBRX icon
5088
Forte Biosciences
FBRX
$1.57B
$637K ﹤0.01%
17,488
-26,966
-61% -$1.02M
NETL icon
5089
Colterpoint Net Lease Real Estate ETF
NETL
$53.9M
$637K ﹤0.01%
21,692
+9,517
+78% +$276K
TSAT icon
5090
Telesat
TSAT
$757M
$637K ﹤0.01%
38,642
+25,102
+185% +$559K
PUI icon
5091
Invesco Dorsey Wright Utilities Momentum ETF
PUI
$55.6M
$636K ﹤0.01%
17,339
-14,202
-45% -$491K
SPRO icon
5092
Spero Therapeutics
SPRO
$70.1M
$635K ﹤0.01%
72,996
+22,511
+45% +$231K
RBB icon
5093
RBB Bancorp
RBB
$463M
$634K ﹤0.01%
26,989
+8,384
+45% +$215K
DNA.WS
5094
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$633K ﹤0.01%
719,268
SCLEU
5095
DELISTED
Broadscale Acquisition Corp. Units
SCLEU
$633K ﹤0.01%
63,100
WMPN
5096
DELISTED
William Penn Bancorporation Common Stock
WMPN
$630K ﹤0.01%
49,391
+613
+1% +$7.71K
NUVB icon
5097
Nuvation Bio
NUVB
$2.16B
$629K ﹤0.01%
119,552
-47,716
-29% -$268K
SAMG icon
5098
Silvercrest Asset Management
SAMG
$79.2M
$628K ﹤0.01%
30,702
+1,676
+6% +$29.9K
TCRT icon
5099
Alaunos Therapeutics
TCRT
$4.79M
$628K ﹤0.01%
6,417
+422
+7% +$54.2K
CAN
5100
Canaan Creative
CAN
$171M
$625K ﹤0.01%
114,989
-238,324
-67% -$1.19M

Similar funds

Morgan Stanley's Q1 2022 Portfolio in Review

As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
  • Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
  • Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
  • Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
  • Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
  • Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
  • Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.